中国医师杂志2024,Vol.26Issue(7) :990-994.DOI:10.3760/cma.j.cn431274-20240419-00672

抗NMDAR脑炎的病因及诊疗研究进展

Research progress on the etiology and diagnosis and treatment of anti NMDAR encephalitis

徐振宏 凌鑫 段晓梅 唐北沙
中国医师杂志2024,Vol.26Issue(7) :990-994.DOI:10.3760/cma.j.cn431274-20240419-00672

抗NMDAR脑炎的病因及诊疗研究进展

Research progress on the etiology and diagnosis and treatment of anti NMDAR encephalitis

徐振宏 1凌鑫 1段晓梅 1唐北沙2
扫码查看

作者信息

  • 1. 南华大学附属第一医院神经内科、脑疾病多组学研究中心,湖南省免疫相关性脑病临床研究中心,衡阳 421000
  • 2. 南华大学附属第一医院神经内科、脑疾病多组学研究中心,湖南省免疫相关性脑病临床研究中心,衡阳 421000;中南大学湘雅医院神经内科、国家老年疾病临床医学研究中心(湘雅医院),长沙 410008
  • 折叠

摘要

抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎是一种罕见的自身免疫性脑炎,其病因与临床表现的多样性使其备受关注,但目前抗NMDAR脑炎的病因及发病机制尚未完全明确,其诊治仍存在一定的局限性.本综述主要探讨驱动疾病发生的环境遗传因素及有利于诊断疾病的生物学指标,并阐述目前的免疫调节和新兴治疗途径,指出潜在的靶向干预措施,并展望其面临的挑战与未来的发展方向.

Abstract

Anti N-methyl-D-aspartate receptor(NMDAR)encephalitis is a rare autoimmune encephalitis,and its diverse etiology and clinical manifestations have attracted attention.However,the etiology and pathogenesis of anti NMDAR encephalitis are not yet fully understood,and its diagnosis and treatment still have certain limitations.This review mainly explores the environmental genetic factors that drive the occurrence of diseases and the biological indicators that are beneficial for diagnosis.It also elaborates on the current immune regulation and emerging treatment pathways,points out potential targeted interventions,and looks forward to the challenges and future development directions they face.

关键词

抗N-甲基-D-门冬氨酸受体脑炎/生物标记

Key words

Anti-N-methyl-D-aspartate receptor encephalitis/Biomarkers

引用本文复制引用

出版年

2024
中国医师杂志
中华医学会 湖南省医学会

中国医师杂志

CSTPCD
影响因子:0.876
ISSN:1008-1372
段落导航相关论文